Insulin composition providing alternatives to immunological resistance
AssigneeHoechst Aktiengesellschaft
InventorsAdolf Mager, Hans-Hermann Schone, Rolf Geiger, Franz Enzmann
Life of this patent
Estimating the term…
Abstract
A novel insulin composition of improved stability and compatibility comprising in an aqueous suspension crystallized insulin and amorphous des-phenyl-alanine.sup.B1 insulin of the same species, and a method for its manufacture.
Claims4
An insulin composition for providing an alternative to an immunological resistance to insulin of different mixed species of insulin which comprises, in an aqueous suspension, a crystallized insulin and an amorphous des-phenyl-alanine.sup.B1 insulin of the same species, having a pH value in the range of from 6.8 to 7.6, containing zinc ions in an amount of up to 340.gamma./100 I.U., wherein the insulin crystals have a uniform size of from 15 to 35 microns;
- wherein the ratio of crystallized insulin to amorphous des-phenyl-alanine.sup.B1 insulin ranges from 60 :
- 40 to 80 :
- 20;
- and wherein the insulin content is from 40 to 80 I.U. per ml.
Dependencies are inferred from the claim text.